SCHEMBL502176

SCHEMBL502176

CCCCCCCCCCCCCCC(N)=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOAT1 P35610 2/20 0.74
▸ MEN1 O00255 2/20 0.74
▸ KMT2A Q03164 2/20 0.74
▸ FAAH O00519 1/20 0.74
▸ TP53 P04637 1/20 0.74
▸ CYP1A2 P05177 1/20 0.74
▸ CYP3A4 P08684 1/20 0.74
▸ CYP2C19 P33261 1/20 0.74
▸ KDM4E B2RXH2 2/20 0.65
▸ CES2 O00748 3/20 0.65
▸ CES1 P23141 3/20 0.65
▸ GPR84 Q9NQS5 7/20 0.62
▸ PPARG P37231 6/20 0.62
▸ PPARD Q03181 6/20 0.62
▸ PPARA Q07869 6/20 0.62
▸ HDAC11 Q96DB2 5/20 0.62
▸ TSHR P16473 4/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ TLR2 O60603 2/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218994 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Nonanoamide SCHEMBL38252 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL43639 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL669780 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL2806221 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL217645 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL943102 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL10486648 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL1024576 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL22319678 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 — — US claimed
WO-2024233871-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 — — WO claimed
CN-109891532-B Method for producing rare earth magnet TDK株式会社 2022-04-08 — — CN claimed
CN-109135873-A A kind of oil-soluble graphite ene compound and the preparation method and application thereof 中国石油化工股份有限公司 2019-01-04 — — CN claimed
WO-2014066613-A2 SPHINGOLIPID METABOLITE MIMETICS ZHEJIANG UNIVERSITY (CN) 2014-05-01 — — WO claimed
WO-2011070140-A2 LUBRICATING OIL COMPOSITION SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2011-06-16 — — WO claimed
WO-2008147228-A1 TREATMENT OR PREVENTION OF BONE CONDITIONS FONTERRA CORPORATE RESEARCH AND DEVELOPMENT LIMITED (NZ) 2008-12-04 — — WO claimed
US-20020155496-A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device BIO MERIEUX (FR) 2002-10-24 — — US claimed
EP-1100773-A1 SATURATED AND UNSATURATED ABIETANE DERIVATIVES, DERIVED CONJUGATES AND USES IN A DIAGNOSTIC COMPOSITION, A REAGENT AND A DEVICE BIOMERIEUX (FR) 2001-05-23 — — EP claimed
WO-2000007982-A1 SATURATED AND UNSATURATED ABIETANE DERIVATIVES, DERIVED CONJUGATES AND USES IN A DIAGNOSTIC COMPOSITION, A REAGENT AND A DEVICE BIO MERIEUX (FR) 2000-02-17 — — WO claimed
EP-0781801-B1 Silica-filled rubber compositions containing dialkyleneamide polysulfides GOODYEAR TIRE & RUBBER (US) 1999-09-15 — — EP claimed
US-5080999-A Light-sensitive diazo resin composition containing a higher fatty acid or higher fatty acid amide FUJI PHOTO FILM CO., LTD. (JP) 1992-01-14 — — US claimed
EP-0107850-B1 AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-06 — — EP claimed
US-4493831-A ANTIBIOTICS, VIRICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 — — US claimed
EP-0107850-A1 Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-09 — — EP claimed
US-4000194-A PREPARATION OF ALKYLAMIDES TEXACO INC. (US) 1976-12-28 — — US claimed
US-3954460-A Method of sinter coating metal strips with metallic powder using fatty acid amide as a temporary adhesive INLAND STEEL COMPANY (US) 1976-05-04 — — US claimed
CN-115667599-B Heat storage composition 住友化学株式会社 2026-05-12 — — CN disclosed
US-3983178-A Immonium salts and derivatives thereof HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1976-09-28 — — US disclosed
US-3959373-A Amide compounds LEVER BROTHERS COMPANY (US) 1976-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020155496-A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device C1R, CBR1, CNR1 SOAT1 908/4885MEN1 2776/4885KMT2A 3874/4885
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION NCLN, NCL, RPS13 SOAT1 396/4885MEN1 3411/4885KMT2A 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback